Differential sensitivity of melanoma cell lines with <it>BRAF</it><sup><it>V600E </it></sup>mutation to the specific Raf inhibitor PLX4032
<p>Abstract</p> <p>Blocking oncogenic signaling induced by the <it>BRAF</it><sup>V600E </sup>mutation is a promising approach for melanoma treatment. We tested the anti-tumor effects of a specific inhibitor of Raf protein kinases, PLX4032/RG7204, in melanoma cell lines. PLX4032 decreased signaling t...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2010-04-01
|
| Rangatū: | Journal of Translational Medicine |
| Urunga tuihono: | http://www.translational-medicine.com/content/8/1/39 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
